No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
OPGN OpGen
- 0.5411
- -0.0219-3.89%
Trading Apr 25 09:52 ET
6.83MMarket Cap-86P/E (TTM)
0.5552High0.5411Low19.49KVolume0.5552Open0.5630Pre Close10.64KTurnover0.16%Turnover RatioLossP/E (Static)12.62MShares3.840052wk High2.55P/B6.59MFloat Cap0.165052wk Low--Dividend TTM12.18MShs Float54399.9510Historical High--Div YieldTTM2.50%Amplitude0.1650Historical Low0.5450Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
OpGen Gets Notice of Noncompliance From Nasdaq
OpGen (OPGN) said Tuesday it received a notice from the Nasdaq Stock Market that it was out of compliance with a rule requiring it to file its annual report with the US Securities and Exchange Commiss
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
PDF Version ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, "OpGen" or "the Company") announced today that it received a notice from The Nasdaq Stock Market LLC ("
Express News | OpGen - on April 11 Entered Employment Agreement With David Lazar Post Which Lazar Will Act as Co's Chief Executive Officer
Express News | OpGen 13D Filing Shows David E. Lazar Reported A 19.9% Stake In The Co As Of March 25, 2024
OpGen Inc Secures $3M Investment, Enhances Corporate Structure
Express News | OpGen Shares Are Trading Lower as the Stock Pulls Back After Surging on Tuesday
Comments
Seasoned Private Investor Secures 19.99% Stake In Medical Company
How David Lazar's Strategic Investment in OpGen Could Affect Your Portfolio.
In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock...
In a move that has caught the attention of investors and industry observers alike, David E. Lazar, a seasoned private investor known for his keen eye for value, has recently made a significant investment in OpGen, Inc. (Nasdaq: OPGN). On March 25, 2024, Lazar acquired a substantial stake in the company, purchasing 200,000 shares of Series E Preferred Stock...
Going up monday?
$OpGen(OPGN.US$ 3/29/24 OpGen, Inc. has struck a deal with investor David E. Lazar, who will purchase 3 million shares of Series E Convertible Preferred Stock for $3 million. The initial payment of $200,000 has been made for 200,000 shares, with the rest to follow by May 1, 2024.
$OpGen(OPGN.US$ 🚀 for more gain
$OpGen(OPGN.US$ double bottom 🚀
1
3
Medical Company Announces Preferred Stock Acquisition: New CEO Invests $3M
OpGen's New Dawn: David Lazar’s $3M Investment and Leadership Shift - What It Means for You.
In an ambitious move that could significantly alter its trajectory, OpGen, Inc., a key player in the precision medicine industry based in Rockville, Maryland, has announced a strategic shift that puts private investor David Lazar at the helm as the new CEO. This development follows Lazar's substantial investment of $3 million in pr...
In an ambitious move that could significantly alter its trajectory, OpGen, Inc., a key player in the precision medicine industry based in Rockville, Maryland, has announced a strategic shift that puts private investor David Lazar at the helm as the new CEO. This development follows Lazar's substantial investment of $3 million in pr...
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg